CONCLUSIONS Isolation and culture of primary CSCs with 37 C coating cell culture bottles and modified CGM is a more superior method, which lays the foundation for the further experimental study.
METHODS Human umbilical vein endothelial cells (HUVECs) was divided into 3 groups: the normal control group cultivated in DEME medium with 5.5 mmol/L glucose; the high glucose group (HG) cultivated in DEME medium with 33 mmol/L glucose for 24 h after the IR model was set up; the rosiglitazone group cultivated in DEME medium with 33 mmol/L glucose and 10 mmol/L of rosiglitazone for 24 h after the IR model was set up. The cell viability, nitric oxide(NO), endothelin-1(ET-1), mitochondrial membrane potential, reactive oxygen species(ROS), p-IKK and IkBa protein levels were detected.
RESULTS Compared with the normal control, the cell viability, the level of NO and the mitochondrial membrane potential were decreased, levels of ET-1 and ROS increased, p-IKK expression was upregulated, and IkBa expression was down-regulated in HG group(all P<0.01). Rosiglitazone reversed these changes(P<0.05).
CONCLUSIONS Rosiglitazone has the protective effect on insulin resistance induced by high glucose in vascular endothelial cells via inhibiting ROS/IKK signaling pathway.
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A study of the mechanism of valsartan pre-protecting adriamycin-induced cardiotoxicity Lili Meng, Qin Yu Affilated Zhongshan Hospital of Dalian University OBJECTIVES To investigate the effects of valsartan pre-protects adrimycin-induced cardiotoxicity and the mechanism.
METHODS 61 of 8w SD rats were devided into 4groups as follows: Control group (n¼9) were feeded normally; adrimycin-induced cardiotoxicity() group:intraperitoneal ADR,2.5mg/(kg.w), totally 6 weeks, cumulative dose was 15mg/kg. Group C (n¼17): valsartan (low dose) intervened (VLD) group, Group D: valsartan(high dose) intervened group(VHD). In group C and D, valsartan was separately (10mg/(kg.d) and30mg/(kg.d)) given from the first dose of adriamycin, totally 6 weeks. After 6 weeks administration of valsartan and adriamycin, observed 4 weeks. Use echocardiography to detect LVEF, LVFS, LVESD, LVEDD. Take the heart out of the chest to do measure hearts' weight. And then do HE, Sirius red staining. Count out CVF. Use ELISA kits to detect the content of RAS and ROS in cardiac tissues. Use qRT-PCR to detect collagen I, collagen III, caspase3 and caspase8's expressions.
RESULTS
(1) Compared with blank control group, renin, angiotensin II, aldosterone synthase, ROS in the myocardial tissues of the model group are evidently overexpressed (P <0.05); In group model, rats' myocardial tissue, caspase3, caspase8 mRNA levels increased significantly (P <0.05), the myocardial collagen volume increased significantly (P<0.05).
(2) Valsartan high dose group compared with blank control group, there was no significant statistical differences about indexes above (P >0.05). compared with model control group, the valsartan high dose group and the blank control group, there were significant differences about the above indexes (P < 0.05).
(3) There were no significant differences in LVEDD among the four groups (P >0.05); About LVESD, LVEF, LVFS, there were no significant difference between the valsatan low dose group and the model control group. The above index average were less than the model control group and the valsartan low dose group, The differences among the three groups were significant (P <0.05), Compared with the high dose group and the blank control group, the above indexes in model control group were higher. The differences were significant(P <0.05). There were no difference between the valsartan high dose group and blank control group (P >0.05).
CONCLUSIONS
(1) Adriamycin might via activing RAS in rats' myocardial tissues to cause angiotensin overexpressed. Angiotensin-stimulatied to generate more ROS. So the superabundant ROS caused the myocardial apoptosis and fibrosis.
(2) Appling enough dose (load dose) valsartan from the first dose of adriamycin could against AT1 in rats' myocardial tissues. So it could down-regulate the expression of NOX1 and NOX4 and the ROS decreased. In the end, the myocardial apoptosis and fibrosis would be alleviated. However early application of small dose valsartan had no protective effect on adriamycin induced cardiotoxicity. (3) Sufficient and early use of valsartan in adriamycin chemotherapy rats could prevent rats suffering Cardiotoxicity. The mechanism might related to NOX1 and NOX4 mediated oxidative stress.
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Endothelial progenitor cells join in HHcy impaired angiogenesis Xiao Huang, Hong Wang, Xiaoshu Cheng The second hospital of Nanchang University OBJECTIVES During the last decade, we and others have demonstrated that HHcy can inhibit endothelial cell growth and postinjury reendothelialization, accelerate neointimal formation, also can impair endothelial relaxation, stimulate vascular smooth muscle cell proliferation, and inhibit high-density lipoprotein biosynthesis. However, the fundamental basis of HHcy-impaired angiogenesis remains unknown, especially the role of endothelial progenitor cells in angiogenesis.
Role of endothelial progenitor cell in HHcy impaired angiogenesis. Intravenous transfusions of Sca-1þ cells maybe play a role in HHcy MI mice angiogenesis.
METHODS
1. Angiogenesis of HHcy mice under myocardial infarction. 1.1 Cardiac function was measured with echocardiography (VisualSonics Vevo 770); 1.2 Hearts were moved at 2 weeks/6 weeks after myocardial infarction and kept at -80 C until needed. Frozen heart tissues were cut into 5mm thick slices. Adjacent sections (taken at the midpoint between LAD ligation site and apex) were stained with rabbit polyclonal antibodies against CD31.
2. Flow cytometry analysis. A volume of 200ml peripheral blood/ bone marrow were incubated for 30 minutes in the dark with monoclonal antibodies against mouse vascular endothelial growth factor receptor 2 (VEGFR2) followed by PE-conjugated secondary antibody.
3. MACS Separation-purify Sca-1þ cells. Purity of Sca-1þ cell is based on the use of MACS MicroBeads, MACS Columns and MACS Separators.
4. Intravenous transfusions of Sca-1þ cells in HHcy MI mice angiogenesis. To evaluate the homing to infarcted heart of injected cells, 200ml purified Sca-1þ cells were labeled with CellVueR NIR (nearinfrared) 780 (Excitation max: 745nm/Emission max: 776nm, Mol. Targeting Tech. Inc. West Chester, PA) and injected peri-orbitally into C57/B6 mice, 6 hours before MI procedure.
RESULTS
1. HHcy impairs mouse cardiac function. Ejection fraction (EF) and fractional shortening (FS) were lower in HHcy mice group than control group, as well as heart capillary density. HHcy mice hearts have depressed function and less capillary density after myocardial infarction stress. Survival rate is also lower in HHcy mice.
2. Peripheral blood derived EPC percentage decreased in HHcy mice group and bone marrow derived EPC percentage is higher in HHcy mice group, but cell death rate is also higher in HHcy mice.
3. Intravenous transfusion of Sca-1þ cells treatment induce PB derived EPC percentage increase in both control mice group and HHcy mice group. 6 weeks survival rate increased from 12.5% to 27.3% in hCBSþCbs-/-cell treat group, and also 62.5% to 80% in hCBSþCbsþ/-cell treat group; The LVEF increased from 19.3% to 38.5% in hCBSþCbs-/-cell treat group, and also 31.6% to50.9% in hCBSþCbsþ/-cell treat group.
CONCLUSIONS EPC joined angiogenesis after myocardial infarction which is so important to cardiac function. Cell treatment restores ischemia-induced angiogenesis in HHcy mice.
